Ahmed Samir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed Samir has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Ayman M Abdelrahman Elsayed
Department of Ophthalmology, Zagazig University, Zagazig, Sharkia, Egypt
3 shared publications Ayman Abdelrahman
Zagazig Univ, Ophthalmol Dept, 55026,3rd Ahmed Orabi St, Zagazig 44511, Egypt
2 shared publications- Ayman Lotfy
Ophthalmology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
2 shared publications - Ayman Lotfy
Assistant Professor of Ophthalmology, Ophthalmology Department, Zagazig University, Zagazig, Egypt
2 shared publications Abdelrahman M Gameel
Department of Vascular Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt
1 shared publicationAhmed A. M. Gad
Zagazig Univ, Ophthalmol Dept, 55026,3rd Ahmed Orabi St, Zagazig 44511, Egypt
1 shared publication
Latest Publications
- 24 April 2026
- Published by Wolters Kluwer Health in Saudi Journal of Ophthalmology
Novel technique for fixating the plate of the Ahmed valve to the sclera using a single-flanged prolene suture
PURPOSE: The purpose of this study was to evaluate a novel technique for fixating the plate of the Ahmed glaucoma valve (AGV) to the sclera using a single-flanged prolene suture. METHODS: This study involved 40 eyes of 40 patients diagnosed with different types of primary and secondary open-angle glaucoma who had undergone AGV implantation with plate fixation using a single-flanged prolene suture technique. The clinical data regarding the duration of surgery, intra- and postoperative complications, best-corrected visual acuity, intraocular pressure (IOP), and the number of IOP-lowering drugs were retrieved. RESULTS: The mean age of patients was 50.3 ± 11.8 years. The average follow-up period was 5.3 ± 1.7 months. The mean duration of surgery was 25.3 ± 6.7 min. Preoperatively, all patients were on full antiglaucoma medication with a mean IOP of 32.4 ± 6.3 mmHg. Significantly lower postoperative IOP than at baseline at all visits ( P < 0.05) was found. Postoperative IOP at 1 week, 1 month, and 3 months were 11.8 ± 3.6, 14.2 ± 4.2, and 15.3 ± 2.6 mmHg, respectively ( P = 0.002). In this study, complete success occurred in 30 (75%) cases, while qualified success was encountered in the remaining 10 (25%) cases with stable IOP 6-21 mmHg on a fixed dorzolamide–timolol glaucoma combination. The number of IOP-lowering medications was 1.8 ± 0.3 postoperative compared to 3.8 ± 0.4 preoperative. No cases of exposed or migrated tubes or plates were reported in this study. No major post operative complications in the form of tube touch to the iris, tube occlusion, shallow anterior chamber, hypotony, or choroid effusion occurred in this study. CONCLUSION: This novel technique of fixating the plate of AGV to the sclera using a single-flanged prolene suture is an efficient, safe, and reproducible technique that provides excellent stability without complications of free plate techniques and at the same time minimizes risks of conventional old valve plate fixation techniques.
- 24 April 2026
- Published by Wolters Kluwer Health in Saudi Journal of Ophthalmology
Novel technique for fixating the plate of the Ahmed valve to the sclera using a single-flanged prolene suture
PURPOSE: The purpose of this study was to evaluate a novel technique for fixating the plate of the Ahmed glaucoma valve (AGV) to the sclera using a single-flanged prolene suture. METHODS: This study involved 40 eyes of 40 patients diagnosed with different types of primary and secondary open-angle glaucoma who had undergone AGV implantation with plate fixation using a single-flanged prolene suture technique. The clinical data regarding the duration of surgery, intra- and postoperative complications, best-corrected visual acuity, intraocular pressure (IOP), and the number of IOP-lowering drugs were retrieved. RESULTS: The mean age of patients was 50.3 ± 11.8 years. The average follow-up period was 5.3 ± 1.7 months. The mean duration of surgery was 25.3 ± 6.7 min. Preoperatively, all patients were on full antiglaucoma medication with a mean IOP of 32.4 ± 6.3 mmHg. Significantly lower postoperative IOP than at baseline at all visits ( P < 0.05) was found. Postoperative IOP at 1 week, 1 month, and 3 months were 11.8 ± 3.6, 14.2 ± 4.2, and 15.3 ± 2.6 mmHg, respectively ( P = 0.002). In this study, complete success occurred in 30 (75%) cases, while qualified success was encountered in the remaining 10 (25%) cases with stable IOP 6-21 mmHg on a fixed dorzolamide–timolol glaucoma combination. The number of IOP-lowering medications was 1.8 ± 0.3 postoperative compared to 3.8 ± 0.4 preoperative. No cases of exposed or migrated tubes or plates were reported in this study. No major post operative complications in the form of tube touch to the iris, tube occlusion, shallow anterior chamber, hypotony, or choroid effusion occurred in this study. CONCLUSION: This novel technique of fixating the plate of AGV to the sclera using a single-flanged prolene suture is an efficient, safe, and reproducible technique that provides excellent stability without complications of free plate techniques and at the same time minimizes risks of conventional old valve plate fixation techniques.
- Open Access
- 19 August 2022
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 16, 2699-2703
The Role of Automated Peripheral Iridectomy Combined with Phacoemulsification and Mini Ex-PRESS Shunt Implantation in Patients with Chronic Angle Closure Glaucoma
Purpose: To evaluate the role of automated peripheral iridectomy as an adjunctive tool combined with phacoemulsification and ExPRESS shunt implantation in management of cases with chronic angle closure glaucoma. Setting: Magrabi eye hospital. Methods: This prospective study included 22 eyes of 22 patients with chronic angle closure glaucoma and cataract who underwent Ex-PRESS shunt implantation, cataract extraction and surgical peripheral iridectomy at the site of shunt implantation in the period between January 2018 and April 2020. Results: After surgery, the mean IOP was 11.3± 1.2 mm Hg, 14.5± 1.6 mm Hg, 14.8± 2.1 mm Hg, 15.3± 1.9 mm Hg and 17.4± 1.8 mm Hg at 7 days, 1 month, 3 months, 6 months and 12 months, respectively. All postoperative IOP was significantly lower compared with preoperative IOP (P = 0.001). There was a significant decrease in the number of medications required after surgery. The baseline mean number of medications was 3.4± 0.02 (range from 1 to 4), while postoperatively the mean number of medications decreased to 0.7± 0.01 at 12 months (P < 0.01). The qualified success rate was 6/22 eyes, and the complete success rate was 16/22 (72.7%) at 12 months, respectively. Conclusion: The combined phacoemulsification and Ex-PRESS shunt implantation with automated peripheral iridectomy is an effective and safe procedure to treat chronic angle closure glaucoma.
- 19 August 2022
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 16, 2699-2703
Open AccessThe Role of Automated Peripheral Iridectomy Combined with Phacoemulsification and Mini Ex-PRESS Shunt Implantation in Patients with Chronic Angle Closure Glaucoma
Purpose: To evaluate the role of automated peripheral iridectomy as an adjunctive tool combined with phacoemulsification and ExPRESS shunt implantation in management of cases with chronic angle closure glaucoma. Setting: Magrabi eye hospital. Methods: This prospective study included 22 eyes of 22 patients with chronic angle closure glaucoma and cataract who underwent Ex-PRESS shunt implantation, cataract extraction and surgical peripheral iridectomy at the site of shunt implantation in the period between January 2018 and April 2020. Results: After surgery, the mean IOP was 11.3± 1.2 mm Hg, 14.5± 1.6 mm Hg, 14.8± 2.1 mm Hg, 15.3± 1.9 mm Hg and 17.4± 1.8 mm Hg at 7 days, 1 month, 3 months, 6 months and 12 months, respectively. All postoperative IOP was significantly lower compared with preoperative IOP (P = 0.001). There was a significant decrease in the number of medications required after surgery. The baseline mean number of medications was 3.4± 0.02 (range from 1 to 4), while postoperatively the mean number of medications decreased to 0.7± 0.01 at 12 months (P < 0.01). The qualified success rate was 6/22 eyes, and the complete success rate was 16/22 (72.7%) at 12 months, respectively. Conclusion: The combined phacoemulsification and Ex-PRESS shunt implantation with automated peripheral iridectomy is an effective and safe procedure to treat chronic angle closure glaucoma.
- Open Access
- 1 October 2020
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 14, 3131-3136
Scleral Fixation of Single-Piece Foldable IOL Using Double-Flanged Technique
Purpose: To describe the efficiency and visual results of a new method of transconjunctival intrascleral fixation of single-piece foldable IOL using double-flanged 6/0 prolene suture. Materials and Methods: Seventeen aphakic eyes of 17 patients without adequate capsular support were involved in this study. Lens was prepared by passing the 6/0 prolene suture in a track in the haptic of single-piece foldable IOL created by 31 g needle. The 6/0 prolene suture was retrieved through a 30 g needle transconjunctivally to outside the globe; then, IOL was implanted and a terminal bulb was created at the outer end of the prolene suture. Results: All cases were aphakic after complicated phacoemulsification. In 10 cases hydrophilic IOLs were used and in 7 cases hydrophobic IOLs were used. There is clear statistically significant difference between pre-UCVA and post- UCVA. Complications included suture slippage in 2 cases and prolene bulb exposure in one case. There was no significant difference in endothelial cell count and IOP before and after 3 months. Conclusion: Transconjunctival intrascleral fixation of foldable single-piece IOLs is a safe efficient method for correcting aphakia.
- 1 October 2020
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 14, 3131-3136
Open AccessScleral Fixation of Single-Piece Foldable IOL Using Double-Flanged Technique
Purpose: To describe the efficiency and visual results of a new method of transconjunctival intrascleral fixation of single-piece foldable IOL using double-flanged 6/0 prolene suture. Materials and Methods: Seventeen aphakic eyes of 17 patients without adequate capsular support were involved in this study. Lens was prepared by passing the 6/0 prolene suture in a track in the haptic of single-piece foldable IOL created by 31 g needle. The 6/0 prolene suture was retrieved through a 30 g needle transconjunctivally to outside the globe; then, IOL was implanted and a terminal bulb was created at the outer end of the prolene suture. Results: All cases were aphakic after complicated phacoemulsification. In 10 cases hydrophilic IOLs were used and in 7 cases hydrophobic IOLs were used. There is clear statistically significant difference between pre-UCVA and post- UCVA. Complications included suture slippage in 2 cases and prolene bulb exposure in one case. There was no significant difference in endothelial cell count and IOP before and after 3 months. Conclusion: Transconjunctival intrascleral fixation of foldable single-piece IOLs is a safe efficient method for correcting aphakia.
- Open Access
- 1 April 2020
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 14, 1055-1058
Double-Flanged polypropylene Suture for Scleral Fixation of Cionni Capsule Tension Ring
Purpose: To describe a new technique for transconjunctival intrascleral fixation of Cionni CTR using double-flanged polypropylens suture. Methods: This is a prospective interventional case series which included 7 cases with severe (more than 180 degrees) zonular dialysis. Three cases were hereditary lens subluxation (Marfan syndrome), 2 cases with traumatic subluxation and 2 cases with pseudo-exfoliation syndrome. Results: All cases achieved a good postoperative stable and centered IOL with good visual results. No postoperative complications were recorded apart from PCO in 3 cases and mild bleeding during needle passage in one case. Conclusion: This described technique is a simple, time sparing and minimally invasive method for achieving good bag centration. It eliminates the need of conjunctival peritomy, subconjunctival vessels cautery and scleral fashioning of a flap, pocket or a groove. The use of 6/0 polypropylene theoretically can achieve better longevity.
- 1 April 2020
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 14, 1055-1058
Open AccessDouble-Flanged polypropylene Suture for Scleral Fixation of Cionni Capsule Tension Ring
Purpose: To describe a new technique for transconjunctival intrascleral fixation of Cionni CTR using double-flanged polypropylens suture. Methods: This is a prospective interventional case series which included 7 cases with severe (more than 180 degrees) zonular dialysis. Three cases were hereditary lens subluxation (Marfan syndrome), 2 cases with traumatic subluxation and 2 cases with pseudo-exfoliation syndrome. Results: All cases achieved a good postoperative stable and centered IOL with good visual results. No postoperative complications were recorded apart from PCO in 3 cases and mild bleeding during needle passage in one case. Conclusion: This described technique is a simple, time sparing and minimally invasive method for achieving good bag centration. It eliminates the need of conjunctival peritomy, subconjunctival vessels cautery and scleral fashioning of a flap, pocket or a groove. The use of 6/0 polypropylene theoretically can achieve better longevity.
- Open Access
- 1 October 2019
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 13, 2075-2080
Novel Technique For The Management Of Macroperforation During Deep Anterior Lamellar Keratoplasty
Purpose: To describe the outcomes of a case series of patients who underwent a novel technique for managing macroperforation during deep anterior lamellar keratoplasty (DALK). Methods: Nine eyes of 9 patients with advanced keratoconus who underwent DALK comprised the case series. A macroperforation occurred in all eyes during DALK. The stromal patch suturing technique was used to manage all cases; a large piece of the previously excised stromal tissue was sutured to the edge of the trephine to seal the perforation. The technical aspects of the procedure are described and data are presented on the visual outcomes, endothelial microscopy, and postoperative complications at last postoperative visit (average 18 months; range, 7 to 23 months). Results: All 9 cases were managed successfully with the stromal patch suturing technique. Postoperatively, the graft was clear in all cases. At day 1, seven eyes had a Descemet’s membrane detachment, 3 of these eyes resolved spontaneously within 2 weeks and 4 required air bubble injection for successful reattachment. At last follow up seven eyes had a corrected distance visual acuity of 20/30 or better and 2 eyes had 20/40 vision. The average endothelial cell count was 2162 cell/mm2. There were no cases with excessive inflammation or vascularisation during the postoperative follow-up. Conclusion: The stromal patch suturing technique was successfully used to manage intraoperative macroperforation during DALK. This technique resulted in endothelial changes that were consistent with uncomplicated DALK and function visual acuity of 20/40 or better in all cases with no postoperative sequelae.
- 1 October 2019
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 13, 2075-2080
Open AccessNovel Technique For The Management Of Macroperforation During Deep Anterior Lamellar Keratoplasty
Purpose: To describe the outcomes of a case series of patients who underwent a novel technique for managing macroperforation during deep anterior lamellar keratoplasty (DALK). Methods: Nine eyes of 9 patients with advanced keratoconus who underwent DALK comprised the case series. A macroperforation occurred in all eyes during DALK. The stromal patch suturing technique was used to manage all cases; a large piece of the previously excised stromal tissue was sutured to the edge of the trephine to seal the perforation. The technical aspects of the procedure are described and data are presented on the visual outcomes, endothelial microscopy, and postoperative complications at last postoperative visit (average 18 months; range, 7 to 23 months). Results: All 9 cases were managed successfully with the stromal patch suturing technique. Postoperatively, the graft was clear in all cases. At day 1, seven eyes had a Descemet’s membrane detachment, 3 of these eyes resolved spontaneously within 2 weeks and 4 required air bubble injection for successful reattachment. At last follow up seven eyes had a corrected distance visual acuity of 20/30 or better and 2 eyes had 20/40 vision. The average endothelial cell count was 2162 cell/mm2. There were no cases with excessive inflammation or vascularisation during the postoperative follow-up. Conclusion: The stromal patch suturing technique was successfully used to manage intraoperative macroperforation during DALK. This technique resulted in endothelial changes that were consistent with uncomplicated DALK and function visual acuity of 20/40 or better in all cases with no postoperative sequelae.
- Open Access
- 6 February 2019
- Published by Springer Nature in BMC Ophthalmology
- Vol. 19 (1) , 1-7
Combined phacoemulsification and viscocanalostomy with Ologen implant versus combined phacoemulsification and viscocanalostomy
To study the efficacy of the biodegradable collagen implant Ologen® as an adjuvant in phaco-viscocanalostomy in patients with coexisting cataract and primary open angle glaucoma. This prospective, interventional, randomized clinical study was done at Alpha Vision Center, Zagazig, Egypt. Patients with coexisting cataract and glaucoma were randomized to receive either phaco-viscocanalostomy (Phacovisco group) (39 eyes) or phaco-viscocanalostomy with Ologen® implant (OloPhacovisco group) (40 eyes). Follow-up period was 2 years. Nd:YAG laser goniopuncture was done in cases where the intraocular pressure (IOP) was elevated above 21 mmHg after discontinuation of corticosteroid eye drops at any follow-up visit. No significant operative or postoperative complications (other than failure) were encountered in either group. At 2 years follow-up, the mean IOP level was statistically significantly decreased in the OloPhacovisco group (p = 0.02) and complete success occurred in 23 eyes (59.0%) in the Phacovisco group and in 32 eyes (80.0%) in the OloPhacovisco group. There was a statistically significant higher success rate regarding complete success in patients that received Ologen® implant (p = 0.04). Ologen® implant improved the success rate of phaco-viscocanalostomy. Larger studies with longer follow-up periods may be required to confirm these findings. This trial was retrospectively registered on 20/12/2018 under the number ( NCT03782051 ).
- 6 February 2019
- Published by Springer Nature in BMC Ophthalmology
- Vol. 19 (1) , 1-7
Open AccessCombined phacoemulsification and viscocanalostomy with Ologen implant versus combined phacoemulsification and viscocanalostomy
To study the efficacy of the biodegradable collagen implant Ologen® as an adjuvant in phaco-viscocanalostomy in patients with coexisting cataract and primary open angle glaucoma. This prospective, interventional, randomized clinical study was done at Alpha Vision Center, Zagazig, Egypt. Patients with coexisting cataract and glaucoma were randomized to receive either phaco-viscocanalostomy (Phacovisco group) (39 eyes) or phaco-viscocanalostomy with Ologen® implant (OloPhacovisco group) (40 eyes). Follow-up period was 2 years. Nd:YAG laser goniopuncture was done in cases where the intraocular pressure (IOP) was elevated above 21 mmHg after discontinuation of corticosteroid eye drops at any follow-up visit. No significant operative or postoperative complications (other than failure) were encountered in either group. At 2 years follow-up, the mean IOP level was statistically significantly decreased in the OloPhacovisco group (p = 0.02) and complete success occurred in 23 eyes (59.0%) in the Phacovisco group and in 32 eyes (80.0%) in the OloPhacovisco group. There was a statistically significant higher success rate regarding complete success in patients that received Ologen® implant (p = 0.04). Ologen® implant improved the success rate of phaco-viscocanalostomy. Larger studies with longer follow-up periods may be required to confirm these findings. This trial was retrospectively registered on 20/12/2018 under the number ( NCT03782051 ).
- 1 January 2019
- Published by Egyptian Knowledge Bank in The Egyptian Journal of Surgery
- Vol. 38 (1) , 136-141
The 1470 radial endovenous laser ablation of the great saphenous vein larger than 12 mm: is it a good option? A single-center experience
Introduction Endovenous ablation of varicose veins has been used to treat varicose veins and has gained popularity as one of the preferred techniques to treat axial reflux. Initially the diameter recommended was less than 8 mm, then gradually surgeons starting gaining the experience to treat larger veins. Treating larger veins has been on the controversial side with some surgeons recommending surgery versus others recommending endovenous ablation. Patients and methods The patients were divided to three groups according to the great saphenous vein diameter and follow-up duplex arranged at 3, 6, and 2 months. Visual analog scale was used at 1 week and 4 weeks to assess postoperative pain. Results In our study, there was no incidence of deep venous thrombosis (DVT) or nerve injury in any of our groups. At 1 month, there was significant difference between the groups, but at 4 weeks there was no significant difference regarding postoperative pain. There was no recanalization with an occlusion percentage of 100% in the 3-month duplex scan in all the groups. There is no significant statistical difference between the groups regarding recanalization at 6 and 12 months. Conclusion Our study showed good short-term results of endovenous laser therapy in the ablation of large-diameter great saphenous vein. The use of endovenous laser therapy has to be a dynamic process where you as an endovascular surgeon can change a variety of parameters to optimize the final results of the procedure.
- 1 January 2019
- Published by Egyptian Knowledge Bank in The Egyptian Journal of Surgery
- Vol. 38 (1) , 136-141
The 1470 radial endovenous laser ablation of the great saphenous vein larger than 12 mm: is it a good option? A single-center experience
Introduction Endovenous ablation of varicose veins has been used to treat varicose veins and has gained popularity as one of the preferred techniques to treat axial reflux. Initially the diameter recommended was less than 8 mm, then gradually surgeons starting gaining the experience to treat larger veins. Treating larger veins has been on the controversial side with some surgeons recommending surgery versus others recommending endovenous ablation. Patients and methods The patients were divided to three groups according to the great saphenous vein diameter and follow-up duplex arranged at 3, 6, and 2 months. Visual analog scale was used at 1 week and 4 weeks to assess postoperative pain. Results In our study, there was no incidence of deep venous thrombosis (DVT) or nerve injury in any of our groups. At 1 month, there was significant difference between the groups, but at 4 weeks there was no significant difference regarding postoperative pain. There was no recanalization with an occlusion percentage of 100% in the 3-month duplex scan in all the groups. There is no significant statistical difference between the groups regarding recanalization at 6 and 12 months. Conclusion Our study showed good short-term results of endovenous laser therapy in the ablation of large-diameter great saphenous vein. The use of endovenous laser therapy has to be a dynamic process where you as an endovascular surgeon can change a variety of parameters to optimize the final results of the procedure.
- 1 November 2018
- Published by Wolters Kluwer Health in Eye & Contact Lens: Science & Clinical Practice
- Vol. 44 (2) , S192-S195
Conjunctival Autograft Combined With Either Preoperative Mitomycin C Injection or Intraoperative Local Mitomycin C Over the Medial Rectus Muscle Tendon in Primary Pterygium Surgery
Purpose: To evaluate and compare the recurrence rate and complications of conjunctival autograft (CAG) combined with preoperative mitomycin C (MMC) injection versus CAG with intraoperative local MMC over the medial rectus muscle tendon in primary pterygium. Study Design: Randomized prospective study. Methods: This study included 108 eyes of 108 patients with primary fleshy or growing pterygium. All patients were from rural areas and less than 50 years old. Fifty-three patients were treated with injection of 0.1 mL of 0.15 mg/mL MMC into the body of pterygium followed 1 day later by pterygium excision and CAG (group I), and 55 patients were treated with pterygium excision and local application of 0.2 mg/mL MMC for 2 min over the medial rectus tendon followed by CAG (group II). The minimum follow-up period was 18 months. Results: Two patients from group I and one patient from group II did not complete the follow-up period and were excluded. There were no statistically significant differences between the two groups regarding age, sex, laterality, or follow-up period. Recurrence occurred in 2 eyes in group I (3.92%) and 1 eye in group II (1.85%); (P=0.52). All recurrences occurred in male patients of less than 30 years of age. No significant complications were encountered in both groups. Conclusions: Both preoperative MMC injection followed 1 day later by pterygium excision with CAG, and pterygium excision and intraoperative local application of MMC on the medial rectus tendon are successful in treating primary pterygium with low recurrence rate and few complications.
- 1 November 2018
- Published by Wolters Kluwer Health in Eye & Contact Lens: Science & Clinical Practice
- Vol. 44 (2) , S192-S195
Conjunctival Autograft Combined With Either Preoperative Mitomycin C Injection or Intraoperative Local Mitomycin C Over the Medial Rectus Muscle Tendon in Primary Pterygium Surgery
Purpose: To evaluate and compare the recurrence rate and complications of conjunctival autograft (CAG) combined with preoperative mitomycin C (MMC) injection versus CAG with intraoperative local MMC over the medial rectus muscle tendon in primary pterygium. Study Design: Randomized prospective study. Methods: This study included 108 eyes of 108 patients with primary fleshy or growing pterygium. All patients were from rural areas and less than 50 years old. Fifty-three patients were treated with injection of 0.1 mL of 0.15 mg/mL MMC into the body of pterygium followed 1 day later by pterygium excision and CAG (group I), and 55 patients were treated with pterygium excision and local application of 0.2 mg/mL MMC for 2 min over the medial rectus tendon followed by CAG (group II). The minimum follow-up period was 18 months. Results: Two patients from group I and one patient from group II did not complete the follow-up period and were excluded. There were no statistically significant differences between the two groups regarding age, sex, laterality, or follow-up period. Recurrence occurred in 2 eyes in group I (3.92%) and 1 eye in group II (1.85%); (P=0.52). All recurrences occurred in male patients of less than 30 years of age. No significant complications were encountered in both groups. Conclusions: Both preoperative MMC injection followed 1 day later by pterygium excision with CAG, and pterygium excision and intraoperative local application of MMC on the medial rectus tendon are successful in treating primary pterygium with low recurrence rate and few complications.
- 1 September 2018
- Published by Wolters Kluwer Health in Retina
- Vol. 38 (9) , 1795-1800
EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
Purpose: To compare the safety, efficacy, and frequency of intravitreal injection of aflibercept and bevacizumab for treatment of macular edema secondary to central retinal vein occlusion. Design: Prospective, comparative, randomized, interventional study. Patients and Methods: Eyes with macular edema secondary to central retinal vein occlusion were randomized between two groups according to the intravitreal injection used. Group A included eyes treated with intravitreal aflibercept, and Group B included eyes treated with intravitreal bevacizumab injections. The inclusion criteria were macular edema secondary to central retinal vein occlusion and follow-up duration of at least 12 months after the first injection. Exclusion criteria were macular ischemia, associated diabetes, hypertensive or renal retinopathy, other retinal disease, and previous anti–vascular endothelial growth factor injection. The main outcome measures are central foveal thickness, best-corrected visual acuity, time intervals between injections, improved retinal nonperfusion, and any reported complication. Results: Group A included 39 patients with a mean age of 57.4 ± 8.2 years. Group B included 40 eyes with a mean age of 56.5 ± 9.1 years. Twelve months after the first injection, central foveal thickness significantly improved from 475.45 ± 71.05 m to 259.11 ± 20.67 m in Group A and from 460.22 ± 89.38 m to 264.29 ± 32.05 m in Group B; best-corrected visual acuity significantly improved from 0.81 ± 0.16 logarithm of the minimum angle of resolution (20/125) to 0.34 ± 0.14 logarithm of the minimum angle of resolution (20/40) in Group A and from 0.73 ± 0.15 logarithm of the minimum angle of resolution (20/100) to 0.33 ± 0.17 logarithm of the minimum angle of resolution (20/40) in Group B; the mean number of injections was 3.72 ± 2.93 in Group A and was 5.44 ± 2.85 in Group B (P < 0.05); and the mean interval between injections was 54.23 ± 8.47 days in Group A and was 35.12 ± 7.76 days in Group B (P < 0.05). Retinal nonperfusion improved in 9/12 eyes in Group A and in 3/8 eyes in Group B (P < 0.05). Conclusion: Both aflibercept and bevacizumab are comparably effective for treatment of macular edema secondary to central retinal vein occlusion without significant complications. However, the burden of frequent intravitreal injections could be significantly reduced when using aflibercept.
- 1 September 2018
- Published by Wolters Kluwer Health in Retina
- Vol. 38 (9) , 1795-1800
EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
Purpose: To compare the safety, efficacy, and frequency of intravitreal injection of aflibercept and bevacizumab for treatment of macular edema secondary to central retinal vein occlusion. Design: Prospective, comparative, randomized, interventional study. Patients and Methods: Eyes with macular edema secondary to central retinal vein occlusion were randomized between two groups according to the intravitreal injection used. Group A included eyes treated with intravitreal aflibercept, and Group B included eyes treated with intravitreal bevacizumab injections. The inclusion criteria were macular edema secondary to central retinal vein occlusion and follow-up duration of at least 12 months after the first injection. Exclusion criteria were macular ischemia, associated diabetes, hypertensive or renal retinopathy, other retinal disease, and previous anti–vascular endothelial growth factor injection. The main outcome measures are central foveal thickness, best-corrected visual acuity, time intervals between injections, improved retinal nonperfusion, and any reported complication. Results: Group A included 39 patients with a mean age of 57.4 ± 8.2 years. Group B included 40 eyes with a mean age of 56.5 ± 9.1 years. Twelve months after the first injection, central foveal thickness significantly improved from 475.45 ± 71.05 m to 259.11 ± 20.67 m in Group A and from 460.22 ± 89.38 m to 264.29 ± 32.05 m in Group B; best-corrected visual acuity significantly improved from 0.81 ± 0.16 logarithm of the minimum angle of resolution (20/125) to 0.34 ± 0.14 logarithm of the minimum angle of resolution (20/40) in Group A and from 0.73 ± 0.15 logarithm of the minimum angle of resolution (20/100) to 0.33 ± 0.17 logarithm of the minimum angle of resolution (20/40) in Group B; the mean number of injections was 3.72 ± 2.93 in Group A and was 5.44 ± 2.85 in Group B (P < 0.05); and the mean interval between injections was 54.23 ± 8.47 days in Group A and was 35.12 ± 7.76 days in Group B (P < 0.05). Retinal nonperfusion improved in 9/12 eyes in Group A and in 3/8 eyes in Group B (P < 0.05). Conclusion: Both aflibercept and bevacizumab are comparably effective for treatment of macular edema secondary to central retinal vein occlusion without significant complications. However, the burden of frequent intravitreal injections could be significantly reduced when using aflibercept.
- Open Access
- 1 January 2012
- Published by Medknow in Saudi Journal of Ophthalmology
- Vol. 26 (1) , 87-90
Percaruncular single injection peribulbar anaesthesia in patients with axial myopia for phacoemulsification
Myopia has been identified as a risk factor for globe perforation during regional anaesthesia for cataract surgery. We conducted this study to evaluate efficacy of single injection percaruncular peribulbar anaesthesia for phacoemulsification in patients with axial myopia. Eighty patients with axial myopia received percaruncular peribulbar anaesthesia and were evaluated for incidence of major or minor complications. Also surgeon and patients' satisfaction and their comment on operative conditions were noted. Of the 80 patients 51 patients had posterior staphylomas. About three quarters of the patients developed adequate akinesia in 10 min. Remaining 25% received second injection with the same technique but with less volume after which the percent of patients with adequate akinesia rose to 91%. Adequate analgesia developed in almost all patients and only in one patient, intravenous analgesia was necessary to complete the operation. All operations were completed uneventfully. No perforations or penetrations were recorded and no other major complications were encountered. About 97% of the surgeons and 96% of the patients found the operative conditions satisfactory. Using single injection percaruncular peribulbar local anaesthesia for phacoemulsification in patients with axial myopia is an effective technique.
- 1 January 2012
- Published by Medknow in Saudi Journal of Ophthalmology
- Vol. 26 (1) , 87-90
Open AccessPercaruncular single injection peribulbar anaesthesia in patients with axial myopia for phacoemulsification
Myopia has been identified as a risk factor for globe perforation during regional anaesthesia for cataract surgery. We conducted this study to evaluate efficacy of single injection percaruncular peribulbar anaesthesia for phacoemulsification in patients with axial myopia. Eighty patients with axial myopia received percaruncular peribulbar anaesthesia and were evaluated for incidence of major or minor complications. Also surgeon and patients' satisfaction and their comment on operative conditions were noted. Of the 80 patients 51 patients had posterior staphylomas. About three quarters of the patients developed adequate akinesia in 10 min. Remaining 25% received second injection with the same technique but with less volume after which the percent of patients with adequate akinesia rose to 91%. Adequate analgesia developed in almost all patients and only in one patient, intravenous analgesia was necessary to complete the operation. All operations were completed uneventfully. No perforations or penetrations were recorded and no other major complications were encountered. About 97% of the surgeons and 96% of the patients found the operative conditions satisfactory. Using single injection percaruncular peribulbar local anaesthesia for phacoemulsification in patients with axial myopia is an effective technique.